These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 26996624)

  • 1. Phosphorylation Processes Controlling Aromatase Activity in Br east Cancer: An Update.
    Catalano S; Barone I; Marsico S; Bruno R; Andò S
    Mini Rev Med Chem; 2016; 16(9):691-8. PubMed ID: 26996624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogens and PTP1B function in a novel pathway to regulate aromatase enzymatic activity in breast cancer cells.
    Barone I; Giordano C; Malivindi R; Lanzino M; Rizza P; Casaburi I; Bonofiglio D; Catalano S; Andò S
    Endocrinology; 2012 Nov; 153(11):5157-66. PubMed ID: 22962253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid estradiol/ERalpha signaling enhances aromatase enzymatic activity in breast cancer cells.
    Catalano S; Barone I; Giordano C; Rizza P; Qi H; Gu G; Malivindi R; Bonofiglio D; Andò S
    Mol Endocrinol; 2009 Oct; 23(10):1634-45. PubMed ID: 19556341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid estrogen effects on aromatase phosphorylation in breast cancer cells.
    Catalano S; Barone I; Andò S
    Methods Mol Biol; 2014; 1204():155-63. PubMed ID: 25182769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of steroid sulfatase in local formation of estrogen in post-menopausal breast cancer patients.
    Nakata T; Takashima S; Shiotsu Y; Murakata C; Ishida H; Akinaga S; Li PK; Sasano H; Suzuki T; Saeki T
    J Steroid Biochem Mol Biol; 2003 Sep; 86(3-5):455-60. PubMed ID: 14623544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diversity of mechanisms involved in aromatase regulation and estrogen action in the brain.
    Charlier TD; Cornil CA; Ball GF; Balthazart J
    Biochim Biophys Acta; 2010 Oct; 1800(10):1094-105. PubMed ID: 20060879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural and functional characterization of aromatase, estrogen receptor, and their genes in endocrine-responsive and -resistant breast cancer cells.
    Chan HJ; Petrossian K; Chen S
    J Steroid Biochem Mol Biol; 2016 Jul; 161():73-83. PubMed ID: 26277097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aromatase and breast cancer.
    Chen S
    Front Biosci; 1998 Aug; 3():d922-33. PubMed ID: 9696881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The selective estrogen enzyme modulators in breast cancer: a review.
    Pasqualini JR
    Biochim Biophys Acta; 2004 Jun; 1654(2):123-43. PubMed ID: 15172700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent insight on the control of enzymes involved in estrogen formation and transformation in human breast cancer.
    Pasqualini JR; Chetrite GS
    J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):221-36. PubMed ID: 15860265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aromatase in aging women.
    Bulun SE; Zeitoun K; Sasano H; Simpson ER
    Semin Reprod Endocrinol; 1999; 17(4):349-58. PubMed ID: 10851574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of aromatase expression in breast cancer tissue.
    Bulun SE; Lin Z; Zhao H; Lu M; Amin S; Reierstad S; Chen D
    Ann N Y Acad Sci; 2009 Feb; 1155():121-31. PubMed ID: 19250199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphorylation of human placental aromatase CYP19A1.
    Ghosh D; Egbuta C; Kanyo JE; Lam TT
    Biochem J; 2019 Nov; 476(21):3313-3331. PubMed ID: 31652308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between aromatase and cyclooxygenases in breast cancer: potential for new therapeutic approaches.
    Brueggemeier RW; Díaz-Cruz ES
    Minerva Endocrinol; 2006 Mar; 31(1):13-26. PubMed ID: 16498361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Possible role of the aromatase-independent steroid metabolism pathways in hormone responsive primary breast cancers.
    Hanamura T; Niwa T; Gohno T; Kurosumi M; Takei H; Yamaguchi Y; Ito K; Hayashi S
    Breast Cancer Res Treat; 2014 Jan; 143(1):69-80. PubMed ID: 24292869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aromatase overexpression enhances the stimulatory effects of adrenal androgens on MCF7 breast cancer cells.
    Maggiolini M; Bonofiglio D; Pezzi V; Carpino A; Marsico S; Rago V; Vivacqua A; Picard D; Andò S
    Mol Cell Endocrinol; 2002 Jul; 193(1-2):13-8. PubMed ID: 12160997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast cancer tissue estrogens and their manipulation with aromatase inhibitors and inactivators.
    Geisler J
    J Steroid Biochem Mol Biol; 2003 Sep; 86(3-5):245-53. PubMed ID: 14623518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent developments in steroidal and nonsteroidal aromatase inhibitors for the chemoprevention of estrogen-dependent breast cancer.
    Ahmad I; Shagufta
    Eur J Med Chem; 2015 Sep; 102():375-86. PubMed ID: 26301554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of R264C and R264H polymorphisms in human aromatase function.
    Baravalle R; Di Nardo G; Bandino A; Barone I; Catalano S; Andò S; Gilardi G
    J Steroid Biochem Mol Biol; 2017 Mar; 167():23-32. PubMed ID: 27702664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Keratinocyte growth factor (KGF) induces aromatase activity in cultured MCF-7 human breast cancer cells.
    Zhang Y; Kulp SK; Sugimoto Y; Farrar WB; Brueggemeier RW; Lin YC
    Anticancer Res; 1998; 18(4A):2541-6. PubMed ID: 9703907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.